Navigation Links
Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
Date:12/7/2011

JACKSONVILLE, Fla. -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida. Their report, published online in Gynecologic Oncology, suggests that this combination (ixabepilone and sunitinib), might offer a much needed treatment option for women with advanced ovarian cancer. When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it.

"Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance which may be what this combination of agents is doing would be a boon to treatment of this difficult cancer," says study co-author Gerardo Colon-Otero, M.D., a hematologist-oncologist who cares for ovarian cancer patients.

The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. The study's senior investigator, cancer biologist John Copland, Ph.D., has identified RhoB as a key modulator for drug response in other tumor types, but says its role in ovarian cancer was unknown before this study.

"Now we find that with this combination of drugs, RhoB is increased and cells die," he says.

The study was possible because Dr. Copland and his laboratory colleagues, including co-author Laura Marlow, created and characterized two new ovarian laboratory cell lines. They were derived from tumor tissue specimens taken from a patie
'/>"/>

Contact: Kevin Punsky
Punsky.Kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pycnogenol® found to improve memory and test scores in college students in new clinical trial
2. American Society of Clinical Oncology issues annual report on progress against cancer
3. Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy
4. Mayo Clinic research improves diagnosis and potential treatment of neuromyelitis optica
5. Newly established neuroscience clinical trials center could bring treatments to patients faster
6. 2011 ASH Annual Meeting to highlight latest hematology research, clinical care breakthroughs
7. BMC resident receives American Society for Clinical Pathology awards
8. First whole-genome sequencing clinical trials for triple-negative breast cancer presented
9. Researchers validate preclinical effectiveness of TB drug target
10. Use of retail medical clinics rises 10-fold over 2-year period, study finds
11. AAOS issues new clinical practice guideline for treating common elbow fractures in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine silicate ... is hosting the Nitrosigine Pump Challenge at the America’s ... The Arnold Sports Festival in Columbus, Ohio. The event ... 2015. , Nitrosigine is a patented ingredient of ... status; now affirmed as GRAS.^ It has been clinically ...
(Date:3/4/2015)... 2015 Brassica Protection Products LLC, an ... rebrand of its SGS™ brand of glucoraphanin to truebroc™. ... glucoraphanin, which is the most concentrated source of glucoraphanin ... includes a new truebroc logo and refreshed website and ... brand name. , “We are thrilled to unveil ...
(Date:3/4/2015)... 04, 2015 Ada Products Company, ... on Wednesday its strategic partnership with the Dental Exchange ... that will introduce them to engaging, inspiring ideas, products, ... , The Dental Exchange is a first-of-its ... dental industry. Unlike other social platforms, the Dental Exchange ...
(Date:3/4/2015)... TheraBreath is proud to announce a new probiotic lozenge ... with overall health. , Many health experts agree that ... bad bacteria that can cause unwanted infections. While most people ... will need the help of a probiotic to elevate the ... Packed with the S. salivarius M18 & K12 strains of ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... a worrisome public health issue worldwide. The rising prevalence ... economic and social burden in both developed and developing ... is projected to rise to 1.5 billion, equating to ... of these patients are forecast to come from the ...
Breaking Medicine News(10 mins):Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4
... TOWN, W.Va., Feb. 5 ReBuilder Medical Technologies, Inc. ... based treatments for diabetic peripheral neuropathy and ... an increase in sales for the month of January. ... we appear to be recession proof and this monthly ...
... Data will mark 1st official measure of unemployment rate ... The U.S. Department of Labor will, for the first ... disabilities on Friday, Feb. 6. This information will ... conditions affect Americans with disabilities. Although it is ...
... 2009 Narcotics have an irreversible effect on the ... to Dr. Stphane Potvin of the Universit de Montral ... Hospital. , According to his research, some 33 ... drug addiction. The study has shown that drug consumption ...
... the nation,s mayors, U.S. Conference of Mayors President Miami ... the new Congress for taking a bold step towards ... With the signing into law of the Children,s ... extends government health benefits to an additional four million ...
... U.S. Conference of Catholic Bishops (USCCB) has launched ... widely-supported pro-life policies and to oppose the federal ... 24-25, the campaign is being coordinated through the ... Human Life Amendment (NCHLA).To date, tens of millions ...
... the Obama Administration,s call for change comes new momentum ... encompass universal coverage along with evidence-based methods of prevention, ... editorial in the January 2009 issue (Volume 15, Number ... and Complementary Medicine, a peer-reviewed journal published by ...
Cached Medicine News:Health News:ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09 2Health News:U.S. Labor Department to begin new monthly data series on people with disabilities from Current Population Survey on Feb. 6 2Health News:Massive Nationwide Pro-Life Postcard Campaign Underway 2Health News:Alternative and Complementary Medicine Should Have Role in New Era of Health Care Reform 2
(Date:3/4/2015)... 2015 Research and Markets ( ... "Negative Pressure Wound Therapy Market (Conventional and ... Size, Share, Growth, Trends and Forecast 2014 - ... The global negative pressure wound therapy ... geography. By product types the NPWT market is ...
(Date:3/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... 27 th Annual ROTH Conference, taking place March ...  Dr. Michael Berelowitz , Chairman of the ... overview on March 10, 2015.   ...
(Date:3/4/2015)... March 4, 2015  KemPharm, Inc., a clinical-stage ... development of proprietary new molecular entity (NME) prodrugs, ... Woody as Chief Commercial Officer.  Ms. Woody ... commercial experience building businesses for both emerging and ... As Chief Commercial Officer, Ms. Woody ...
Breaking Medicine Technology:Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3KemPharm, Inc. Appoints Tracy M. Woody as Chief Commercial Officer 2
... , , PALO ALTO, Calif. ... biotechnology company, today announced the appointment of Mark W. ... position, Mr. Davis will lead TOPICA,s clinical development activities for ... (nail and nail bed fungal infections) and tinea pedis (athlete,s ...
... , HOUSTON , Feb. 17   , , , ... IN THE DISTRICT COURT OF, ... , ... , ...
Cached Medicine Technology:TOPICA Names Mark W. Davis Vice President of Clinical Development 2TOPICA Names Mark W. Davis Vice President of Clinical Development 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 4Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 5Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 6Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 7Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 8Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 9
MAXM is a reliable benchtop solution for processing mid-size volume workloads. Features include three-dimensional VCS technology, continuous autoloading and easy-to-use data management capabilities....
... LH 755 simplifies and automates ... expert automation and advanced technologies ... reliable, accurate results every time. ... slide quality with its slide-on-slide ...
... from the ground-up with ergonomic concerns in ... most adjustable observation tube on the market. ... user can adjust the microscope to suit ... the operator maintain an upright, comfortable posture, ...
... operates with a simple click of ... Direct the mouse cursor to the ... of the slide and the magnified ... Graphic User Interface (GUI) enables one-click ...
Medicine Products: